Global Peripheral Artery Disease Market: Trends & Opportunities ( ) February 2016

Similar documents
Lower Extremity Arterial Disease

Learning About. Peripheral Artery Disease

DON T LET LEG PAIN BECOME A REAL THREAT.

Introduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9

View Report Details. Global Aortic Aneurysm Market: Trends and Opportunities ( )

Introduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6

EDUCATION. Peripheral Artery Disease

US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts ( ) September 2016

Patient Brochure. Clearstream Technologies, Ltd. Moyne Upper Enniscorthy Co. Wexford, Ireland. PK Rev. 0 05/17

Global Stevia Market: Size, Trends & Forecasts ( ) July 2017

Global Clear Aligner Market: Size, Trends & Forecasts ( ) August 2016

Global Remote Cardiac Monitoring Market: Size, Trends & Forecasts ( )

View Report Details. Global Coronary Stent Market

The US Onychomycosis Market (2017 Edition) July 2017

Peripheral Vascular Disease Patient Awareness

Role of ABI in Detecting and Quantifying Peripheral Arterial Disease

Peripheral Arterial Disease

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

Peripheral Arterial. Disease

ANGIOPLASTY AND STENTING

Imaging for Peripheral Vascular Disease

Global Continence Care Market with Focus on Intermittent Catheter Market ( ) December 2016

Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts ( ) September 2016

Update from Korea on the Lutonix SFA registry 12 month data

A Healthy Heart. IN BRIEF: Your Guide to

Patient Information. Peripheral Arterial Disease and the Lutonix 035 Balloon. Advancing Lives and the Delivery of Health Care

Understanding Peripheral

Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts ( ) April 2017

Percutaneous Transluminal Angioplasty (PTA) and Stenting For PVS Patients

Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit?

Treatment Strategies For Patients with Peripheral Artery Disease

Aortic and Iliac Artery Occlusive Disease (Updated 10.08)

Abdominal Exam: The examination of the abdomen used by physicians to detect an abdominal aortic aneurysm.

What Is PAD? MAY SHOWERS, BRING SPRING FLOWERS! mhtml:file://c:\users\copper Moon Media\Documents\NMFA\newsletters\2017\May

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology

Klinikum Rosenheim Department of Diagnostic and Interventional Radiology

Global Spine Market with Focus on Spinal Fusion: Industry Analysis & Outlook ( )

Evidence-Based Optimal Treatment for SFA Disease

Atherosclerosis. Atherosclerosis happens when the blood vessels

REFERENCE CODE GDME1058CFR PUBLICATION DATE SEPTEMBER 2013 DRUG-ELUTING BALLOONS APAC ANALYSIS AND MARKET FORECASTS

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI

Understanding Peripheral

Lessons learnt from DES in the SFA is there any ideal concept so far?

Alternative concepts for drug delivery in BTK arteries the LIMBO project

Intermittent Claudication

Adventitial Drug Infusion to Prevent Restenosis

# $ pages In Stock. Report Description

The Utility of Atherectomy and the Jetstream Atherectomy System

Global Health Functional Food Market: Size, Trends & Forecasts ( ) December 2016

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia

Choosing Wisely NL. Peripheral Artery Disease

Endovascular Options in Critical Limb Ischemia: Below The Knee Therapies

Device Evolution. Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance. Where Do We Stand? 4/18/2015

Global Spine Market with Focus on Spinal Fusion: Industry Analysis & Outlook ( )

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D.

Hernia Repair Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

SFA CTO Lesion Management laser or directional atherectomy?

One Year after In.Pact Deep: Lessons learned from a failed trial. Prof. Dr. Thomas Zeller

Cordis S.M.A.R.T. and S.M.A.R.T. CONTROL Nitinol System For the Iliac Arteries

Massimiliano Fusaro, MD on behalf of ISAR-STATH Investigators. Deutsches Herzzentrum München, Technische Universität München Munich - Germany

Rapid Recovery Hyperbarics 9439 Archibald Ave. Suite 104 Rancho Cucamonga CA,

Global End Stage Renal Disease (ESRD) Market With Focus on Dialysis Market ( Edition) July 2017

TOBA II 12-Month Results Tack Optimized Balloon Angioplasty

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort

The US Meal Kit Market: Size, Trends & Forecasts ( ) August 2017

Peripheral Vascular/Arterial Disease (PVD/PAD) Patient Guide. Guide contents: 2 What Is PVD/PAD? 3 The Risks 3 Diagnosing the Condition

Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease?

A New Treatment Paradigm Outside-In

Boca Raton Regional Hospital Grand Rounds September 13, 2016

Global Clear Aligners (Invisible Braces) Market: Trends & Opportunities (2015 Edition) December 2015

Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to Hexa Research

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide

Carotid Stenosis (carotid artery disease)

The distinguishing traits of CLI: what makes it so different? Roberto Ferraresi Cardiovascular CathLab

New Data to Shape the Era of Drug Elution in Peripheral Interventions

Co-Conveners: Nadia Wise (Adelaide) and Conor Marron (Adelaide) VASCULAR SOCIETY OF INDIA AND RARE VASCULAR DISORDERS (Combined with: Nursing)

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

The latest generation DEB

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

Femoro-popliteal bypass surgery. Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England.

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

PROCEDURES FOR PERIPHERAL ARTERIAL DISEASE

The latest evidences from the DES trials in peripheral arterial disease

BIOLUX P-III Passeo-18 Lux All-comers Registry: 12-month Results for the All-Comers Cohort

Leg artery disease. Information for patients Sheffield Vascular Institute

Peripheral Vascular Disease

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Recent Advances in Peripheral Salvage

Adventitial Drug Therapy Below-the-Knee: Update on LIMBO and TANGO

Peripheral Vascular Stents for the Lower Extremity

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Peripheral arterial disease for primary care Ed Aboian, MD

First time data release: Initial experience with the temporary Spur Stent System: DEEPER Trial first-in-man results Jihad A. Mustapha, MD, FACC,

Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel

Transcription:

Global Peripheral Artery Disease Market: Trends & Opportunities (2015-2020) February 2016

Global Peripheral Artery Disease Market Report Scope of the Report This report entitled Global Peripheral Artery Disease Market: Trends & Opportunities (2015-2020), analysis the global market for peripheral artery disease and the treatments available for it. The global peripheral artery disease market is analyzed by value, by number of people affected from PAD, PAD by prevalence, by treatment mix and by players in this market. This report also includes forecasting of peripheral artery disease market by value and by number of people affected for the years 2015-2020. The sizing and growth of global peripheral atherectomy market is provided in this report, which includes PAD atherectomy market by value and by players. The forecasting of PAD atherectomy market by value is also provided for the years 2015-2020. This report includes the analysis of global peripheral artery disease device market by value and by product types. This segment of report also includes the sizing and growth of global PAD angioplasty market and global PAD stent market, with focus on drug coated balloons (DCB) market and drug eluting stents (DES) market. This report also provides the analysis of United States peripheral artery disease market. The analysis includes US PAD market by value and by treatment mix. This segment of report also includes US PAD atherectomy market by value and by players and US PAD drug coated balloons (DCB) market by value and by players. Global peripheral artery disease market dynamics are also given in this report which includes the growth drivers, market trends and challenges faced by this market. Company profiling of three major players (Johnson & Johnson, Medtronic Inc. and Stryker Corporation) of peripheral artery disease market is done in this report. Company profiling includes business overview, financial overview and business strategies of each company. Company Coverage Johnson & Johnson Medtronic Inc. Stryker Corporation Country Coverage United States

Global Peripheral Artery Disease Market Report Executive Summary Peripheral artery disease (PAD) is a medical condition in which arteries become narrow due to build-up of plague on the vessel walls. Peripheral artery disease affects the arteries of arms, legs or neurovasculature, other than those that supply the heart and brain. Peripheral artery disease is also known as Peripheral Vascular Disease (PVD) and Peripheral Artery Occlusive Disease. Plaque that deposits in the arteries is made up of fats, cholesterol, calcium, fibrous tissue and other substances in the blood. Plaque formations can grow large enough to significantly reduce the blood's flow through an artery. The main cause of peripheral artery disease is atherosclerosis. Less commonly known causes of peripheral artery disease are blood vessel inflammation, injury to the limbs, unusual anatomy of the ligaments or muscles, or radiation exposure. The risk factors for peripheral artery disease are smoking, obesity, diabetes, hypertension, increasing age etc. Some of the symptoms of this disease are painful cramping in hip, thigh or calf muscles after certain activities, leg numbness or weakness, coldness in lower leg or foot, sores on toes, feet or legs that won't heal, etc. The diagnosis of peripheral artery disease can be done by different techniques and tests such as anklebrachial index (ABI), Doppler ultrasound, treadmill test, magnetic resonance angiogram, blood tests and arteriogram. Treatment of Peripheral artery disease requires multiple approaches, depending on the individual patient. There are two main approaches for the treatment of PAD. The first approach is endovascular treatment, which includes stenting, ballooning and atherectomy. These different treatments can also be used in combination, such as atherectomy with stenting. The second approach is surgical treatment, which includes bypass surgery and amputation. The global peripheral artery disease market has increased with a healthy growth rate in 2014 and is expected to increase further in coming years. The main driving forces for PAD market are increasing population, especially the age group of 65 and above, rising global healthcare expenditure, technological advancements and favorable reimbursement rates for PAD treatment. Yet there are some challenges which PAD industry faces such as restenosis (re-occurrence of PAD post treatment), inappropriate diagnosis and limitations of existing devices.

US$ Billion US$ Billion Global Peripheral Artery Disease Market Overview Global Peripheral Artery Disease Market by Value; 2006-2014 2006 2007 2008 2009 2010 2011 2012 2013 2014 The peripheral artery disease market in 2014 was valued at US$... billion, up by % as compared to 2013. This market is forecasted to reach US$...billion in 2020, at a CAGR of.%.the increase in the peripheral artery disease market is expected due to increasing obese people, increasing population in age group of 60 and above, There are different approaches for the treatment of PAD, that are atherectomy, PTA,.. The larger share in treatment mix is occupied by. with % of share in global peripheral artery disease market in 2014. Global Peripheral Artery Disease Market by Value; 2015-2020 Global Peripheral Artery Disease Market by Treatment Mix; 2014 2015 2016 2017 2018 2019 2020

US$ Million Global Peripheral Artery Disease Market Overview US$ Billion Global PAD Atherectomy Market by Value ; 2012-2020 Global PAD Device Market by Value ; 2014-2020 2012 2013 2014 2015 2016 2017 2018 2019 2020 2014 2015 2016 2017 2018 2019 2020 Global PAD Device Market by Product Type; 2014 The PAD atherectomy market is valued at US$...million in 2014 and is forecasted to increase to US$...million in 2020. The PAD device market has reached to US$...billion in 2014 and is expected to reach to US$... billion in 2020. This increase is expected due to and advancement in technology,.. The PAD device market can be segmented according to the product type, as The share is occupied by in 2014.

Million US Peripheral Artery Disease Market Overview US$ Million US Peripheral Artery Disease Market by Volume ; 2012-2015 US PAD Atherectomy Market by Value ; 2012-2015 Million 2012 2013 2014 2015 In US, prevalence of peripheral artery disease has increased to. million in 2014, up by.% as compared to 2013. This increase is there due to. US peripheral artery disease market by treatment mix is divided into, with..occupying the major share in 2014. US PAD atherectomy market is valued at US$...million in 2014, increasing at a CAGR of %. 2012 2013 2014 2015 US Peripheral Artery Disease Market by Treatment Mix; 2014